PMC:4608092 / 37852-38458 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4608092","sourcedb":"PMC","sourceid":"4608092","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4608092","text":"Figure 14 Tube formation assays for iPSECs after 20 hours of culture on Matrigel with IFN-β. HUVECs without IFN-β treatment served as the control (100%). Total tube length and number of branches were quantified by imaging analysis. A column with a bar represents mean±SD of 2 controls (blue) or 2 patients (red) in 3 independent experiments. *P\u003c0.05, according to Student t test comparing 0 ng/mL of IFN-β within HUVECs, control iPSECs, or patient iPSECs. HUVECs indicates human umbilical vein endothelial cells; IFN, interferon; iPSECs, induced pluripotent stem cell-derived vascular endothelial cells.\n\n","tracks":[]}